Aleeto in Acute ISchemic Stroke:A RandomISed Controlled Clinical Trial

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 192 participants.

Also called NCT06759753

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 192 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06759753
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06759753. Randomized; double masking; primary purpose treatment. Start 2025-03-21 (actual); primary completion 2025-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aleeto in Acute ISchemic Stroke:A RandomISed Controlled Clinical Trial
Acronym
ASSIST
Condition
Acute Ischemic Stroke
Intervention (Drug)
Aleeto
Intervention (Drug)
Placebo
Lead sponsor
Beijing Tiantan Hospital (class: other)

Record details

Record id
cardio:ct-nct06759753
Content hash
21b17eab773e71762d2ee281e972818c4168c03d0c5206813f83a76fdbd63cd2